Cargando…

The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

BACKGROUND: Recent studies suggest that blockade of the NLRP3 (cryopyrin) inflammasome interleukin 1β (IL1β) pathway may offer a new treatment strategy for gout. OBJECTIVE: To explore the potential utility of rilonacept (IL1 Trap) in patients with chronic active gouty arthritis in a proof-of-concept...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terkeltaub, R, Sundy, J S, Schumacher, H R, Murphy, F, Bookbinder, S, Biedermann, S, Wu, R, Mellis, S, Radin, A
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Group 2009
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732898/ https://www.ncbi.nlm.nih.gov/pubmed/19635719 http://dx.doi.org/10.1136/ard.2009.108936

Ejemplares similares

Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
por: Terkeltaub, Robert A, et al.
Publicado: (2013)

Rilonacept (Interleukin-1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Correction to: Rilonacept (Interleukin‑1 Inhibition) for the Treatment of Pericarditis
por: Wang, Tom Kai Ming, et al.
Publicado: (2022)

Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study
por: Bonnekoh, Hanna, et al.
Publicado: (2023)

What makes gouty inflammation so variable?
por: Terkeltaub, Robert
Publicado: (2017)

Rilonacept in the management of cryopyrin-associated periodic syndromes (CAPS)
por: Gillespie, Justin, et al.
Publicado: (2010)

The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever
por: Hashkes, Philip J., et al.
Publicado: (2014)

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
por: Schlesinger, Naomi, et al.
Publicado: (2011)

Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis
por: Affas, Ziad R, et al.
Publicado: (2022)

Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
por: Sieper, Joachim, et al.
Publicado: (2015)

Transition to rilonacept monotherapy from oral therapies in patients with recurrent pericarditis
por: Brucato, Antonio, et al.
Publicado: (2023)

Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial
por: Yang, Deng-Ho, et al.
Publicado: (2023)

SARS-COV-2 AND MRNA VACCINE-ASSOCIATED RECURRENT PERICARDITIS TREATED WITH RILONACEPT
por: Shell, John Clark, et al.
Publicado: (2023)

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
por: Quartier, Pierre, et al.
Publicado: (2010)

Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
por: Perez-Ruiz, Fernando, et al.
Publicado: (2016)

Maternal Deworming Research Study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period
por: Mofid, Layla S, et al.
Publicado: (2015)

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
por: Smolen, J S, et al.
Publicado: (2015)

Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial
por: Klein, Allan L, et al.
Publicado: (2021)

Interleukin‐1 Trap Rilonacept Improved Health‐Related Quality of Life and Sleep in Patients With Recurrent Pericarditis: Results From the Phase 3 Clinical Trial RHAPSODY
por: Brucato, Antonio, et al.
Publicado: (2022)

Rilonacept (IL-1 TRAP) for treatment of colchicine resistant familial mediterranean fever (FMF): a randomized, multicenter double-blinded, alternating treatment trial
por: Hashkes, PJ, et al.
Publicado: (2011)

Goutiness
Publicado: (1906)

Risk of sudden cardiac death in relation to season-specific cold spells: a case–crossover study in Finland
por: Ryti, Niilo R I, et al.
Publicado: (2017)

Coronary stenosis as a modifier of the effect of cold spells on the risk of sudden cardiac death: a case-crossover study in Finland
por: Ryti, Niilo R I, et al.
Publicado: (2018)

Autoinflammatory Features in Gouty Arthritis
por: Galozzi, Paola, et al.
Publicado: (2021)

Efficacy and safety of Tibetan medicine Qingpeng ointment for acute gouty arthritis: protocol for a multi-center, randomized, double-blind, placebo-controlled trial
por: Shang, Ya-xi, et al.
Publicado: (2022)

Overinfection by Paracoccidioides brasiliensis in Gouty Crystal Arthritis
por: Bonilla-Abadía, F., et al.
Publicado: (2012)

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
por: McInnes, Iain B, et al.
Publicado: (2015)

Tolcapone in Obsessive Compulsive disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
por: Grant, Jon E., et al.
Publicado: (2021)

Usefulness of applying research reporting guidelines as Writing Aid software: a crossover randomised controlled trial
por: Hawwash, Dana, et al.
Publicado: (2019)

Gouty tophi
por: Sapkota, Sarita K., et al.
Publicado: (2014)

Gout and Goutiness
Publicado: (1897)

In Gouty Rheumatism
Publicado: (1894)

Gouty Pericementitis
por: Darby, Edwin T.
Publicado: (1895)

Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)
por: Church, Leigh D, et al.
Publicado: (2008)

Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept
por: Lin, David, et al.
Publicado: (2021)

Is ambient air pollution associated with onset of sudden infant death syndrome: a case-crossover study in the UK
por: Litchfield, Ian J, et al.
Publicado: (2018)

Memantine augmentation in clozapine-refractory schizophrenia: a randomized, double-blind, placebo-controlled crossover study
por: Veerman, S. R. T., et al.
Publicado: (2016)

Hydrogen sulfide and traffic-related air pollutants in association with increased mortality: a case-crossover study in Reykjavik, Iceland
por: Finnbjornsdottir, Ragnhildur Gudrun, et al.
Publicado: (2015)

A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine
por: Dzator, Jemima S. A., et al.
Publicado: (2022)

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial
por: Mahomed, Sharana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pda4c2h7f1brhcgm1jua90mjoi